Pegloticase

Brand name: Krystexxa

Rank #245 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$52.2M

Total Cost

Share:

1,134

Total Claims

$52.2M

Total Cost

59

Prescribers

$46K

Cost per Claim

26

Beneficiaries

1,134

30-Day Fills

$885K

Avg Cost/Provider

19

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$52.2M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $52.2M total

🔎 Data Overview

💰

At $46,038 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $884,869 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

👤

Average cost of $2,007,971 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Pegloticase

#ProviderSpecialtyLocationClaimsCost
1Sunil PatelNephrologyApple Valley, CA64$3.6M
2Payam ShakouriNephrologyPoughkeepsie, NY55$3.1M
3James HuntInternal MedicineTarpon Springs, FL69$2.5M
4Gerald HoRheumatologyLa Palma, CA42$2.4M
5Sandra ReedNurse PractitionerTaylorsville, NC41$2.3M
6Po LewFamily PracticeRosemead, CA34$1.9M
7Samer Diab AghaNephrologyFort Lauderdale, FL31$1.8M
8Nizar EskandarNephrologyHinesville, GA24$1.4M
9John KangNephrologyBronx, NY22$1.2M
10Asim SinghNephrologyErie, PA22$1.2M
11Ramachandra MalyaNephrologyHouston, TX20$1.2M
12Joven DungoInternal MedicineJersey City, NJ22$1.1M
13Alex KawanaMedical OncologyWest Hollywood, CA25$1.0M
14Stephen KinardPodiatryTarboro, NC18$1.0M
15Sabeen NajamRheumatologyBaytown, TX17$949K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
242Oxybutynin Chloride (Oxybutynin Chloride Er)$53.4M1,872,901
243Raltegravir Potassium (Isentress)$53.0M25,491
244Belumosudil Mesylate (Rezurock)$52.3M2,280
245Pegloticase (Krystexxa)$52.2M1,134
246Estrogens, Conjugated (Premarin)$52.0M130,171
247Ranolazine (Ranolazine Er)$51.6M381,631
248Epoetin Alfa (Epogen)$51.4M34,952

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology